STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors
- PMID: 16585578
- DOI: 10.4049/jimmunol.176.8.4834
STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors
Abstract
Poorly functional effector CD8 T cells are generated in some pathological situations, including responses to weakly antigenic tumors. To identify the molecular bases for such defective differentiation, we monitored gene expression in naive monoclonal CD8 T cells during responses to TCR ligands of different affinity. We further evaluated whether responses to weak Ags may be improved by addition of cytokines. Transient gene expression was observed for a cluster of genes in response to the weak TCR agonist. Strikingly, gene expression was stabilized by low dose IL-2. This IL-2-sustained gene cluster encoded notably transcripts for CD25, cytolytic effector molecules (granzyme B) and TNF-R family costimulatory molecules (glucocorticoid-induced TNF-R (GITR), OX40, and 4-1BB). IL-2-enhanced surface expression or function was also demonstrated in vivo for these genes. A constitutive active form of STAT5 mimicked the IL-2 effect by sustaining transcripts for the same gene cluster. Consistent with this, under conditions of low avidity TCR engagement and IL-2 treatment, endogenous STAT5 binding to 4-1BB and granzyme B promoters was demonstrated by chromatin immunoprecipitation. This study highlights those genes for which IL-2, via STAT5 activation, acts as a stabilizer of gene regulation initiated by TCR signals, contributing to the development of a complete CD8 T cell effector program.
Similar articles
-
Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.J Immunol. 2013 Oct 1;191(7):3712-24. doi: 10.4049/jimmunol.1300319. Epub 2013 Sep 4. J Immunol. 2013. PMID: 24006458
-
Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor beta-chain expression or STAT5 activation.J Immunol. 2004 Sep 1;173(5):3131-9. doi: 10.4049/jimmunol.173.5.3131. J Immunol. 2004. PMID: 15322173
-
Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo.J Exp Med. 2007 Aug 6;204(8):1803-12. doi: 10.1084/jem.20070543. Epub 2007 Jul 30. J Exp Med. 2007. PMID: 17664293 Free PMC article.
-
IL-15 is a growth factor and an activator of CD8 memory T cells.Ann N Y Acad Sci. 2002 Dec;975:46-56. doi: 10.1111/j.1749-6632.2002.tb05940.x. Ann N Y Acad Sci. 2002. PMID: 12538153 Review.
-
Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation.Eur J Immunol. 2006 Dec;36(12):3090-100. doi: 10.1002/eji.200636347. Eur J Immunol. 2006. PMID: 17111352 Review.
Cited by
-
Profiling of Protein O-GlcNAcylation in Murine CD8+ Effector- and Memory-like T Cells.ACS Chem Biol. 2017 Dec 15;12(12):3031-3038. doi: 10.1021/acschembio.7b00869. Epub 2017 Nov 10. ACS Chem Biol. 2017. PMID: 29125738 Free PMC article.
-
CIS is a potent checkpoint in NK cell-mediated tumor immunity.Nat Immunol. 2016 Jul;17(7):816-24. doi: 10.1038/ni.3470. Epub 2016 May 23. Nat Immunol. 2016. PMID: 27213690
-
Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy.Cancers (Basel). 2019 Nov 21;11(12):1832. doi: 10.3390/cancers11121832. Cancers (Basel). 2019. PMID: 31766350 Free PMC article. Review.
-
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.J Immunol. 2011 Oct 1;187(7):3555-64. doi: 10.4049/jimmunol.1101244. Epub 2011 Aug 31. J Immunol. 2011. PMID: 21880986 Free PMC article.
-
Cytokine signaling in chimeric antigen receptor T-cell therapy.Int Immunol. 2024 Feb 14;36(2):49-56. doi: 10.1093/intimm/dxad033. Int Immunol. 2024. PMID: 37591521 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous